Professor Andrea Brancale



Prosiectau fel Prif Ymchwiliwr
null null 1 o 12 null null

Welsh anti-microbial testing platform - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.06.2015 - 31.12.2018)
In silico platform to support drug discovery and development - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.01.2015 - 31.01.2016)
Molecular modelling studies on piecanatide - Cyllidwr:Synergy Pharmaceuticals Inc (01.07.2015 - 27.01.2016)
Computer-aided design and synthesis of novel anti-DENV nucleoside analogues - Cyllidwr:Henson Research Foundation Inc (01.01.2014 - 31.07.2018)
European training network on antiviral drug development - Cyllidwr:Commission of the European Communities (01.03.2015 - 30.09.2019)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 9 null null

Development of CYP26 inhibitors as neuroblastoma therapeutics - Cyllidwr:Cancer Research UK (01.07.2008 - 31.03.2011)
An innovative approach to new antimicrobial drugs - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2014 - 30.09.2017)
Sensitizing to radiotherapy: Pre clinical evaluation of a novel indication for adjuvant Bcl3i - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 31.12.2016)
The identification and selection of candidate lead compounds against BCL3 - Cyllidwr:BioVitas Capital Ltd, - Cyllidwr:Tiziana Pharma Ltd (01.11.2013 - 13.10.2017)

Diweddarwyd y tro diwethaf ar 2019-06-12 am 04:00